Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/27/2025 | $19.00 | Neutral → Outperform | Mizuho |
| 1/28/2025 | $27.00 | Buy | Truist |
| 7/9/2024 | $28.00 → $30.00 | Neutral → Buy | UBS |
| 6/7/2024 | $25.00 | Neutral | Mizuho |
| 4/9/2024 | $19.00 → $34.00 | Underperform → Outperform | BMO Capital Markets |
| 3/5/2024 | $37.00 → $21.00 | Buy → Neutral | UBS |
| 2/29/2024 | $45.00 → $19.00 | Outperform → Underperform | BMO Capital Markets |
| 12/1/2023 | $28.00 → $40.00 | Sector Perform → Outperform | RBC Capital Mkts |
Collaboration to Focus on Increasing Data Center Efficiency & Sustainability The Chemours Company (Chemours) (NYSE:CC), a global chemistry company, announced a strategic agreement with DataVolt, a designer, developer, and operator of sustainable digital infrastructure, to further demonstrate and develop advanced liquid cooling solutions for data centers alongside other industry leaders. This collaboration will focus on increasing data center efficiency and sustainability through two-phase direct-to-chip, two-phase immersion cooling, and other innovative solutions. The companies will work to enhance infrastructure readiness and address the increasing demands of artificial intelligence (AI)
Partnership to establish initial capacity & enable adoption of Opteon™ two-phase immersion cooling fluid to address data center cooling needs created by AI and next-generation chips The Chemours Company (Chemours) (NYSE:CC), a global chemistry company, announced a strategic agreement with Navin Fluorine International Limited (Navin Fluorine) (NSE: NAVINFLUOR) to manufacture its Opteon™ two-phase immersion cooling fluid. The collaboration is part of Chemours' expanded Liquid Cooling Venture, established to address the growing heat, energy, and water demands of advanced data centers and AI hardware. The partnership with Navin Fluorine marks an important step toward commercialization, providi
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00
Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00
UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously
SD - Chemours Co (0001627223) (Filer)
10-Q - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold its conference call to discuss its first quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 7, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC) is a glo
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the first quarter of 2025. The dividend will be paid on March 14, 2025, to stockholders of record as of the close of business on February 28, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solut
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its fourth quarter 2024 financial results before market on Tuesday, February 18, 2025. The Company expects to hold its conference call to discuss its fourth quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Tuesday, February 18, 2025. The call is open to the public and can be accessed via the webcast information below. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P
Former Hershey and Coca-Cola Executive adds extensive legal, governance, and policy expertise to Chemours' Board of Directors The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Leslie M. Turner to its Board of Directors, effective February 19, 2025. The Company also announced the date for its 2025 Annual Shareholders Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211667601/en/Chemours appoints Leslie M. Turner to its Board
The Chemours Company (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, announced the appointment of Damián Gumpel as President of Chemours' Titanium Technologies (TT) business segment, effective March 3, 2025. Diane Iuliano Picho, who has served as Interim TT Business President since March 2024 has been appointed Chief Enterprise Enablement Officer, effective March 3, 2025. Both will report to Chemours President and CEO, Denise Dignam and serve on the Chemours Executive Team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho